The aim of this study is to investigate the association of immune checkpoint PD-L1 expression and the status of DNA repair gene RAD51B promoter methylation (RAD51Bme) in advanced NSCLC, correlating with patients’ outcome. This evidence concerns the gene CD274 and non-small cell lung carcinoma.